_1553572681956.png?format=webp&height=120&width=120){kind=logo}
Redmile Group - About the company
Redmile Group is an unfunded company based in San Francisco (United States), founded in 2007 by Jeremy Green. It operates as a Long/short equity strategy employee-owned hedge fund. Redmile Group has not raised any funding yet.
Company Details
- Website
- redmilegroup.com
- Registered Address
- San Francisco, California
Key Metrics
Founded Year
2007
Location
San Francisco, United States
Stage
Unfunded
Employee Count
93 as on Jun 30, 2026
Investment & Acquisitions
Legal entities associated with Redmile Group
Redmile Group is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
REDMILE GROUP, LLC CIN: 208592298 , United States, Active | Dec 31, 1999 | - | 34 (As on Dec 31, 2024) | - |
Sign up to download Redmile Group's company profile
Redmile Group's funding and investors
Redmile Group has not raised any funding rounds yet.
Redmile Group's founders and board of directors
Founder? Claim ProfileThe founders of Redmile Group is Jeremy Green.
Here are the details of Redmile Group's key team members:
- Jeremy Green: Founder of Redmile Group.
View details of Redmile Group's Founder profiles and Board Members
Redmile Group's employee count trend
Redmile Group has 93 employees as of Jun 26. Here is Redmile Group's employee count trend over the years:
Uncover Redmile Group's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Redmile Group's Investments and acquisitions
Redmile Group has made 163 investments in companies including Obsidian Therapeutics and Ambrosia Biosciences. Redmile Group has also acquired 1 companies including Redx Pharma.Here is the list of investments & acquisitions:
Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Aug 05, 2026 | Investments | 2015 | Cambridge (United States) | |
Mar 31, 2026 | Investments | 2024 | Boulder (United States) | |
Jan 28, 2026 | Investments | 2009 | Montpellier (France) |
Want to know more about where corporates are investing? Sign up today!See all investments by Redmile Group
Reports related to Redmile Group
Here is the latest report on Redmile Group's geography:
News related to Redmile Group
Filter this listMedia has covered Redmile Group for a total of 7 events in the last 1 year, 1 of them has been about company updates.
•
Colorado biotech Ambrosia lands $100M for oral GLP-1Endpoints•Mar 31, 2026•Ambrosia Biosciences, Blue Owl, Deep Track Capital, Samsara BioCapital and 8 others
•
Impulse Dynamics Completes $158M Financing RoundAgencia EFE•Dec 10, 2025•Impulse Dynamics, Braidwell, Sands Capital, Perceptive Advisors and 3 others
•
Bambusa Therapeutics Completes Series A-2 Financing to Boost Bispecific ProgramsPR Newswire•Nov 17, 2025•RA Capital Management, Athos KG, Bambusa Therapeutics, Salvia and 7 others
•
EQT Life Sciences Co-Leads USD 183 Million Series C Financing in Electra TherapeuticsPR Newswire•Oct 22, 2025•Electra Therapeutics, EQT, Sanofi, Mubadala and 14 others
•
ADC Therapeutics Announces $60 Million Private PlacementPR Newswire•Oct 13, 2025•TCG Crossover, ADC Therapeutics, Redmile Group, Homburger
•
One Biosciences raises $17.5M for oncology platform MobiHealthNews•Jul 22, 2025•One Biosciences, Redmile Group, Galion.exe, Blast.Club and 5 others
•
French AI-driven biotech firm bags $17.4m series ATech in Asia•Jul 18, 2025•One Biosciences, Redmile Group, Blast.Club, Galion.exe and 5 others
•
One Biosciences secures €15M for single-cell oncology platformPharmaTimes•Jul 17, 2025•One Biosciences, Redmile Group, Blast.Club
•
Neuron23 Announces $96.5 Million Series D Financing and Dosing First Patient in NEULARK Clinical TrialBakersfield•Jun 24, 2025•Neuron23, Westlake Village Biopartners, SoftBank Vision Fund, Redmile Group and 3 others
•
Abcuro Announces $200 Million Series C Financing To Advance Its First-in-class Medicine In Development For Inclusion Body Myositisintelligence360•Feb 19, 2025•Abcuro, Soleus Capital, Eurofarma, BlackRock and 11 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Redmile Group
Explore our recently published companies
- Datamap - San Martin based, 2026 founded, Unfunded company
- Aveneo Home - Germany based, 2026 founded, Unfunded company
- Clickfone - Germany based, 2026 founded, Unfunded company
- Aion Systems AI - 2026 founded, Unfunded company
- Arvum Partners - 2026 founded, Unfunded company
- Anticipai - Netherlands based, 2026 founded, Unfunded company
